SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-16-107614
Filing Date
2016-06-09
Accepted
2016-06-09 10:32:46
Documents
6
Period of Report
2016-06-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v442051_8k.htm 8-K 14809
2 EXHIBIT 99.01 v442051_ex99-01.htm EX-99.01 9008
3 EXHIBIT 99.01 v442051_ex99-01.pdf EX-99.01 532027
4 GRAPHIC image_001.jpg GRAPHIC 739222
5 EXHIBIT 99.02 v442051_ex99-02.htm EX-99.02 26491
6 GRAPHIC image_003.jpg GRAPHIC 3907
  Complete submission text file 0001144204-16-107614.txt   1808032
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36019 | Film No.: 161705125
SIC: 2834 Pharmaceutical Preparations